WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016100456) CROSSLINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/100456    International Application No.:    PCT/US2015/066006
Publication Date: 23.06.2016 International Filing Date: 16.12.2015
IPC:
A61K 31/785 (2006.01), A61K 31/787 (2006.01), C08F 226/02 (2006.01), C08F 226/04 (2006.01), C08F 8/00 (2006.01)
Applicants: GENZYME CORPORATION [US/US]; 500 Kendall Street Cambridge, Massachusetts 02142 (US)
Inventors: DHAL, Pradeep K.; (US).
MILLER, Robert J.; (US).
POLOMOSCANIK, Steven C.; (US).
LARSEN, Philip Just; (DE).
HUEBSCHLE, Thomas; (DE).
SCHMIDT, Thorsten; (DE).
DAVISON, Ian; (US).
MCDONNELL, Peter; (US).
AGBUGBA, Chinyere; (US)
Agent: ADAMS, Chandra K.; (US)
Priority Data:
62/093,751 18.12.2014 US
Title (EN) CROSSLINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES
(FR) COPOLYMÈRES POLYDIALLYMINE RÉTICULÉ POUR LE TRAITEMENT DU DIABÈTE DE TYPE 2
Abstract: front page image
(EN)Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
(FR)Des copolymères polydiallylamine sont des copolymères comprenant des monomères de polydiallylamine et soit de polyvinlyamine soit de polyallylamine. Les copolymères de polydiallylamine sont souvent réticulés. Les copolymères de polydiallyamine sont utiles comme compositions pharmaceutiques et peuvent être utilisés dans le traitement du diabète de type 2 et pour atténuer les complications du diabète de type 2.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)